Clinical Trials

314 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03991403 2023-04-03

Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

228 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04646837 2023-03-29

Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01405586 2023-03-24

MILES-3

299 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01656551 2023-03-24

MILES-4

232 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05746598 2023-02-28

Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients

Unknown

178 enrolled

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Diseases, Cardiotoxicity

NCT03574402 2022-12-06

TRUMP

400 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05574998 2022-10-12

FTANLCNDG

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05312840 2022-04-06

Efficacy and Safety of Conventional and Low-dose Platinum Gemcitabine Combined With Cindilimab With Delayed Administration in First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02743923 2021-12-21

Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer

203 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04586465 2021-08-24

DYNAPET

23 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04465942 2021-08-23

Immunotherapy in Lung Cancer: Treatment After IO Cessation.

Unknown

300 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04846452 2021-08-12

Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04865705 2021-04-29

Neoadjuvant Chemotherapy and Tilelizumab in Stage III（cTNM-IIIA.IIIB）Non-small-cell Lung Cancer

33 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02667743 2021-03-17

Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

454 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04768075 2021-02-24

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02977169 2020-11-13

To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

300 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04470076 2020-07-14

Neoafa

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04455594 2020-07-02

ANSWER

168 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Unknown

4,724 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03706287 2020-04-06

Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC

62 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02076477 2020-03-17

OITROLC

420 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02725918 2020-02-12

Pemetrexed vs Pemetrexed Plus Cisplatin in EGFR-mutant NSCLC Patients After First Line EGFR-TKIs Failure

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03062800 2019-06-05

Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)

232 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03374280 2019-03-28

Pemetrexed/Cisplatin Intercalating Gefitinib Treating EGFR Wild NSCLC

178 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01407822 2018-09-11

EMERGING

Phase 2/3 Unknown

72 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03413358 2018-01-29

Clinical Trial for Post-marketing Evaluation of Sheng Bai Oral Liquid

Phase NA Unknown

240 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02734524 2018-01-23

A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer

104 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03201146 2017-11-17

Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

48 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03123445 2017-04-21

Endostar First-line Treatment of Advanced NSCLC

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02844114 2017-03-31

LCKY2015-21(x)

Carcinoma, Non-Small-Cell Lung

NCT03053856 2017-02-15

Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients

37 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03050437 2017-02-10

A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI

96 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01683175 2016-10-20

Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation

94 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01771289 2016-09-27

Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC

50 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02906150 2016-09-19

Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type

140 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02651441 2016-05-24

D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC)

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02766348 2016-05-09

Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients

Carcinoma, Non-Small-Cell Lung

NCT02031601 2016-03-29

TCL-1

Phase 4 Unknown

250 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02643407 2015-12-31

Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer

488 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT02513355 2015-08-04

Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research

Phase 4 Unknown

400 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01843647 2015-07-15

Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01424709 2014-09-25

BRAVO

120 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00006048 2013-12-19

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003240 2013-12-18

Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

1,800 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00004100 2013-12-18

Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00005825 2013-12-18

Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00039039 2013-12-18

Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer

300 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02001896 2013-12-05

Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation